Поисковый запрос: (<.>S=АНТИПАРКИНСОНИЧЕСКИЕ СРЕДСТВА<.>) |
Общее количество найденных документов : 81
Показаны документы с 1 по 20
|
|
1.
| Allelix in pact with Hoechst-Roussel for psychiatric drug development // Emerg. Pharm., 1995. Vol. 4, N 3.-С.4
|
2.
| Allelix in pact with Hoechst-Roussel for psychiatric drug development // Emerg. Pharm., 1995. Vol. 4, N 3.-С.4
|
3.
| Nomoto Application of the common marmoset to pharmacological studies // Nihon yakurigaku zasshi, 1995. Vol. 106, N 1.-С.11-18
|
4.
| Parkinson's disease: Prospects for improved drug therapy // Trends Pharmacol. Sci., 1997. Vol. 18, N 5.-С.156-163
|
5.
| Krzascik Nitric oxide donors antagonize N-nitro-L-arginine and haloperidol catalepsy: Potential implication for the treatment of Parkinsonism? // Pol. J. Pharmacol., 1997. Vol. 49, N 4.-С.263-266
|
6.
| Jain Naveen K. Brain drug delivery system bearing dopamine hydrochloride for effective management of Parkinsonism // Drug Dev. and Ind. Pharm., 1998. Vol. 24, N 7.-С.671-675
|
7.
| Наследственные факторы болезни Паркинсона. Новые лекарства в США и индивидуальный подход // Ido no Nippon, 1998. Vol. 57, N 6.-С.224-225
|
8.
| Synthesis and in vitro and in vivo evaluation of dopaminergic ergoline derivatives // Farmaco, 1998. Vol. 53, N 1.-С.65-72
|
9.
| Guay David R.P. Tolcapone, a selective catechol-O-methyltransferase inhibitor for treatment of Parkinson's disease // Pharmacotherapy, 1999. Vol. 19, N 1.-С.6-20
|
10.
| Guay David R.P. Tolcapone, a selective catechol-O-methyltransferase inhibitor for treatment of Parkinson's disease // Pharmacotherapy, 1999. Vol. 19, N 1.-С.6-20
|
11.
| Greenfield Susan A. Method for treating parkinson's disease employing an ATP-sensitive potassium channel blocker
|
12.
| Вальдман Е.А. Противопаркинсоническая активность нового производного адамантана // Эксперим. и клин. фармакол., 1999. Т. 62, N 4.-С.3-6
|
13.
| Estimation of incidence and prevalence of Parkinson's disease in elderly using pharmacy records // Brit. J. Clin. Pharmacol., 1999. Vol. 48, N 5.-С.779-780
|
14.
| Estimation of incidence and prevalence of Parkinson's disease in elderly using pharmacy records // Brit. J. Clin. Pharmacol., 1999. Vol. 48, N 5.-С.779-780
|
15.
| Predicting antimuscarinic agent poisoning based on clinical signs and symptoms // J. Toxicol. Clin. Toxicol., 2002. Vol. 40, N 5.-С.623-624
|
16.
| Leads for the development of neuroprotective treatment in Parkinson's disease and brain imaging methods for estimating treatment efficacy // Eur. J. Pharmacol., 1999. Vol. 375, N 1-3.-С.75-86
|
17.
| Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor III.: Agonist and antagonist properties at serotonin, 5-HT[1] and 5-HT[2], receptor subtypes // J. Pharmacol. and Exp. Ther., 2002. Vol. 303, N 2.-С.815-822
|
18.
| Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor II.: Agonist and antagonist properties at subtypes of dopamne-D[2]-like receptor and 'альфа'[1]/'альфа'[2]-adrenoceptor // J. Pharmacol. and Exp. Ther., 2002. Vol. 303, N 2.-С.805-814
|
19.
| Rabinowitz Joshua D. Delivery of compounds for the treatment of Parkinsons through an inhalation route
|
20.
| Rabinowitz Joshua D. Delivery of compounds for the treatment of Parkinsons through an inhalation route
|
|
|
|
Главная
Назад
"Электронные каталоги и базы данных библиотек СО РАН"